resources

Sudarshan Pharma Industries Ltd.

BSE: 543828

SME

Sector: Chemicals

Industry Group: Chemicals & Petrochemicals

Industry: Specialty Chemicals

40.80+1.8 (+4.62%)

24 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Sudarshan Pharma Industries Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2023	2024	2025	2026
Annual Reports	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	Jun Sept Dec	—
Conference Calls	—	—	—	—
Presentations	—	—	14Aug	31Jan 15May

Corporate Announcements and Regulatory Filings

Sudarshan Pharma Industries Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201114 Jul 2026
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Hemal Vasantrai Mehta
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations, 2018, received from Kfin Technologies Limited for the quarter ended 30/June/2026.
Closure of Trading Window30 Jun 2026
Closure of Trading Window
The Trading Window of the Company shall remain closed with effect from 01/July/2026 untill the expiry of 48 hours after the declaration of the financial results for the quarter ended 30/June/2026.
Postal Ballot25 Jun 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please find enclosed the Scrutinizer''s Report on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from 26/May/2026 to 24/June/2026.
Postal Ballot25 Jun 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Please find enclosed the voting results on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from 26/May/2026 to 24/June/2026.
Outcome of Board Meeting18 Jun 2026
Board Meeting Outcome for Board Meeting Scheduled On Thursday, 18 June 2026 Cancelled
We would like to inform you that the Meeting of the Board of Directors of the COmpany scheduled today, Thursday, 18/June/2026 stands cancelled due to unavoidable reasons.
Board Meeting15 Jun 2026
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday, 18Th June, 2026
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 ,inter alia, to consider and approve proposal for raising ....
Allotment of Equity Shares12 Jun 2026
Announcement under Regulation 30 (LODR)-Allotment
Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, the Warrants Committee of the Board of Directors of the Company have at their meeting ....
General11 Jun 2026
Meeting Of Warrants Committee Of The Company Scheduled On Thursday, 11/June/2026 Now Postponed To Friday, 12/June/2026
We wish to inform you that the meeting of the Warrants Committee of the Company originally scheduled on 11/June/2026 has been postponed and will now be held on Friday, 12/June/2026.
Acquisition10 Jun 2026
Announcement under Regulation 30 (LODR)-Updates on Acquisition
This is to inform you that Sudarshan Industries Inc. has been incorporated as a wholly-owned subsidiary in United States of America. Details provioded in the Letter and its Annexure.
General8 Jun 2026
Meeting Of Warrants Committee Of The Company On Thursday, 11/June/2026
Pursuant to Regulation 29 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, a Meeting of the Warrants Committee of the Company is scheduled to be held on Thursday, ....
General5 Jun 2026
Intimation As Per Regulation 31 (1) & 31 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Please find enclosed disclosure under Regulation 31(2) of SEBI (Subtsantial Acquisition of Shares and Takeovers) REgulations, 2011 in connection with intimation of pledge.
General4 Jun 2026
Reply To The Email Dated 18Th May 2026 Seeking 'Discrepancies In Financial Results'
We refer to email dated 18/May/2026, referring to discrepancies in financial results for the QUARTER and financial year ended 31/March/2026. We hereby submit the financial results for ....
Reg.24(A)-Annual Secretarial Compliance30 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed the Annual Secretarial Compliance Report issued by Mr. Vishal Manseta, Company Secretary in Practice, for the financial year ended 31/March/2026.
Newspaper Publication26 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the newspaper advertisement for the Postal Ballo Notice dispatched to the shareholders of the Company on 25/May/2026 published in (i) Mumbai Lakshdeep and ....
Postal Ballot25 May 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find enclosed the Notice of Postal Ballot together with Explanatory Statement benig sent to the members of the Company.
General21 May 2026
Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By Listed Entities.
We refer to the Corporate Announcement dated May 15, 2026, (Annexure A) setting out fixed conversion rate of Rs.95.93 per US Dollar for FCCB issue. RBI rate as on date of signing subscription ....
General21 May 2026
Outcome Of Board Meeting Held Today I.E. Thursday, 21St May 2026
The Board of DIrectors at their meeting held today, 21/May/2026, inter alia, approved the following: 1) Migration of equity shares to main Board of BSE and NSE 2) Making Application ....
Allotment of Equity Shares21 May 2026
Announcement under Regulation 30 (LODR)-Allotment
Allotment of USD 10,000,000 8% Senior Unsecured Foreign Currency COnvertible Bonds Due 2029 of the Company.
Board Meeting Rescheduled18 May 2026
Update on board meeting
The Board Meeting to be held on 22/05/2026 has been revised to 21/05/2026 The Board Meeting to be held on 22/05/2026 has been revised to 21/05/2026

Frequently Asked Questions

Where can I download the annual report of Sudarshan Pharma Industries Ltd.?

Annual reports of Sudarshan Pharma Industries Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Sudarshan Pharma Industries Ltd.?

Quarterly earnings results and presentations of Sudarshan Pharma Industries Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Sudarshan Pharma Industries Ltd. publish earnings call transcripts?

Earnings call transcripts of Sudarshan Pharma Industries Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Sudarshan Pharma Industries Ltd.?

Investor presentations and annual day presentations of Sudarshan Pharma Industries Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Sudarshan Pharma Industries Ltd.?

Corporate announcements and regulatory filings of Sudarshan Pharma Industries Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Sudarshan Pharma Industries Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sudarshan Pharma Industries Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Sudarshan Pharma Industries Ltd.?

The ISIN (International Securities Identification Number) of Sudarshan Pharma Industries Ltd. is INE00TV01023. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Sudarshan Pharma Industries Ltd. listed?

Sudarshan Pharma Industries Ltd. is listed on NSE and BSE. The NSE symbol is 543828-BOM and the BSE code is -.

Where can I find the shareholding pattern of Sudarshan Pharma Industries Ltd.?

The quarterly shareholding pattern of Sudarshan Pharma Industries Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Sudarshan Pharma Industries Ltd. on Sharpely?

Share price data for Sudarshan Pharma Industries Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.